The PEA3 subfamily of ETS-domain proteins play important roles in regulating transcriptional activation and have been implicated in several tumorigenic processes. Here we describe the identi®cation of a further member of this family from zebra®sh which most likely represents a homologue of PEA3. A high degree of sequence conservation is observed in the ETS DNAbinding domain and acidic transcriptional activation domain. The DNA binding speci®city of zebra®sh PEA3 is virtually identical to that exhibited by mammalian family members and is autoregulated by cisacting inhibitory domains. Transcriptional activation by zebra®sh PEA3 is potentiated by the ERK MAP kinase and protein kinase A pathways. During embryogenesis, PEA3 is expressed in complex spatial and temporal patterns in both mesodermal somites and ectodermal tissues including the brain, dorsal spinal chord and neural crest. Our characterisation of zebra®sh PEA3 furthers our understanding of its molecular function and its expression pro®le suggests a novel role in cell patterning in the early vertebrate embryo.
Introduction
ETS-domain transcription factors are important transcriptional activators and have been implicated both in tumorigenesis and in several developmental processes. The ETS-domain family is currently composed of more than 30 members from a diverse range of metazoan organisms (Degnan et al., 1993; Laudet et al., 1993) . Each family member contains a conserved region, the ETS-domain, which corresponds to the DNA-binding domain of these proteins. ETSdomain proteins have been implicated in regulating several key developmental processes. For example, Pnt regulates both eye (Brunner et al., 1994; O'Neill et al., 1994) and tracheal (Samakovlis et al., 1996) development in Drosophila whereas in mammals, Ets-1 (Bories et al., 1995; Muthusamy et al., 1995) and PU.1 (Scott et al., 1994; McKercher et al., 1996) have been implicated in regulating dierent aspects of haematopoiesis.
In order to achieve target gene speci®city, many ETS-domain proteins use a bipartite mechanism involving both protein-DNA and protein-protein interactions (reviewed in Crepieux et al., 1994) . Additional speci®city is often required as ETS-domain proteins recognize similar binding sites based on a central 5'-GGAA/T-3' motif although individual proteins binds a distinct spectrum of sites. For example, whereas Ets-1 can tolerate either an A or T residue at the 3' end of the central conserved motif, Elf-1 can only bind eciently to sites containing an A residue (Bosselut et al., 1993) . In the case of Elk-1 the requirement for speci®c residues at given positions extends outside this central region. Indeed, Elk-1 only binds eciently to sites conforming to the extended consensus 5'-AACCGGAAGT-3' whereas the related protein SAP-1 exhibits a relaxed DNA binding speci®city outside the central CCGGA/T core . Binding of a second protein and/ or phosphorylation is also required by several ETSdomain proteins to relieve intramolecular inhibitory mechanisms and thereby permit high anity DNA binding. In the case of Ets-1, the inhibitory mechanism, involving an allosteric change mediated by cooperating C-and N-terminal modules from outside the ETS-domain is well characterized (Jonsen et al., 1996; Skalicky et al., 1996) although the regulatorỳ switch' is unknown. Further studies on the DNA binding properties of other family members are required to establish whether they possess distinct binding speci®cities and autoregulatory mechanisms.
The PEA3 subfamily is composed of three members PEA3, ERM and ER81 in both humans and mice (Xin et al., 1992; Higashino et al., 1993; MonteÂ et al., 1994 MonteÂ et al., , 1995 Brown and McKnight, 1992; Chotteau-Lelievre et al., 1997) . Members of this subfamily share considerable sequence homology. In addition to the ETS-domain, an N-terminal acidic transcriptional activation domain is also highly conserved (reviewed in de . All subfamily members activate transcription from promoters containing ets-motifs (reviewed in de Launoit et al., 1997) . This transactivating activity is further enhanced by stimulation of upstream MAP kinase cascades (Janknecht, 1996; O'Hagan et al., 1996; Janknecht et al., 1996) . Murine PEA3 was originally isolated by its ability to bind the sequence 5'-AGGAAG-3' within the polyomavirus enhancer. However, the binding speci®city of PEA3 subfamily members has not been investigated in detail. DNA binding by full-length murine PEA3 (Xin et al., 1992) and human ERM (Laget et al., 1996) is inhibited by sequences outside the conserved ETS-domain.
PEA3 subfamily members have been associated with several tumorigenic processes (reviewed in de Launoit et al., 1997) and show dierential expression in a range of breast cancer cells . However, at present, their normal functions remains unclear. All three genes are expressed in numerous developing murine organs including the brain, the kidney, the lung and the heart where there is a very striking correlation between the expression of PEA3 group members and epithelial to mesenchymal transitions (Chotteau-Lelievre et al., 1997) . In adults, PEA3 subfamily members exhibit overlapping expression patterns. For example, all three family members are highly expressed in the brain whereas in comparison to ERM, ER81 shows dierential expression and is strongly expressed in the heart but only weakly expressed in placenta (Xin et al., 1992; MonteÂ et al., 1994 MonteÂ et al., , 1995 Brown and McKnight, 1992) . However, to date, it is unclear whether these transcription factors are expressed during early development and whether they play a role in regulating developmental processes.
In order to gain a better understanding of the function of PEA3 subfamily members, we have cloned the zebra®sh homologue of PEA3 and show that it is expressed during the very early stages of development in a variety of embryonic cell types. Zebra®sh PEA3 is highly similar to its mammalian homologues at both the primary amino acid and functional levels. For example, zebra®sh PEA3 activates transcription in a PKA and MAP kinase-regulated manner and exhibits autoinhibition of its DNA binding. Moreover zebra®sh PEA3 also exhibits a virtually indistinguishable DNA binding speci®city to mammalian subfamily members. The developmental pattern of PEA3 expression suggests that it may play a role in the development of the somites and in regionalisation of the nervous system.
Results
The amino acid sequence of PEA3 is highly conserved between mammals and zebra®sh A cDNA encoding part of the conserved ETS DNAbinding domain of PEA3 was ampli®ed from an embryonic zebra®sh cDNA pool using degenerate oligonucleotides and used to screen an embryonic cDNA library. One of the isolated cDNAs (&1.8 kb) was sequenced and shown to contain an open-reading frame of 1482 nucleotides encoding a protein of 494 amino acids with a predicted molecular mass of 55.6 kDa ( Figure 1 ). The predicted initiator codon is preceded by an in-frame stop codon lying three nucleotides upstream. A second in-frame ATG signal is located nine nucleotides downstream. Both translation initiation signals possess good Kozak consensus sequences (Kozak, 1991) and are conserved at the second and third ATGs of the mouse PEA3 cDNA (Figure 2 ; Xin et al., 1992) . However, as ribosomes are thought to locate their initiation sites by scanning, the ®rst initiation signal is likely to be the functionally important one (Kozak, 1991) .
The sequence of the open reading frame shares strong homology with members of the PEA3 subfamily of ETS-domain proteins (Figure 2 ). In particular, high amino acid sequence conservation is exhibited within the ETS-domain (&95% identical) and in an acidic transcriptional activation domain. An additional region of 13 amino acids (245-QTFKQEYMDPLYD-257) is also highly conserved throughout the entire PEA3 subfamily and may represent a third discrete functional domain. The zebra®sh protein shows strongest identity with mouse and human PEA3 (61% and 60.5%, respectively) compared to human ERM (50%) and mouse ER81 (56%) and is therefore likely to represent a zebra®sh homologue of mammalian PEA3.
The transactivation activities of mouse PEA3, human ERM and human ER81 have all been shown to be potentiated by activation of the Ras/MAP kinase and protein kinase A (PKA) signalling cascades (Janknecht, 1996; Janknecht et al., 1996; O'Hagan et al., 1996) . Five putative MAP kinase phosphorylation sites, three optimal (residues 96, 145 and 148) and two minimal (residues 85 and 154), are present in zebra®sh PEA3 suggesting that the activities of this protein may be regulated by MAP kinase-inducted phosphorylation. Two of these sites (residues 96 and 148) are conserved between all members of the PEA3 sub-family and a third (residue 85) is only found in the PEA3 homologues.
The conservation of amino acid sequence and functional domains/motifs suggests that the molecular function of zebra®sh PEA3 is likely to be conserved with its mammalian homologues.
Embryonic expression pattern of zebra®sh PEA3
The expression of PEA3 during early zebra®sh development was analysed by in situ hybridization and found to be both complex and dynamic. PEA3 expression is ®rst detected in zebra®sh embryos after 4.3 h (30% epiboly) throughout the embryo (data not shown). During gastrulation, expression becomes localised around the margin of the blastoderm and a single vertical stripe in the position of the future body axis (Figure 3a) . Expression at the blastoderm margin includes the future mesendoderm, with the stripe in the axis corresponding to axial mesoderm which will later form the notochord and prechordal plate, and more lateral cells of the paraxial mesoderm that form the somites and the head muscles and endothelia. As gastrulation proceeds, the region of PEA3 expressing cells narrows (compare Figure 3b and c) . During the segmentation period (10 ± 24 h) PEA3 expression is downregulated in the axial mesoderm as it matures and becomes restricted to the posterior tip of undifferentiated cells in the tail (Figures 3f ± h, 4b and c) . Likewise, PEA3 expression in the developing somites decreases anteriorly, remaining only in more recently formed segments (Figure 3e ± h and Figure 4e ). Within the somites, expression of PEA3 is restricted to the anterior segment. These observations indicate that PEA3 expression is down-regulated during cellular dierentiation in the mesoderm.
In the head, PEA3 expression is initially observed in regions corresponding to the future forebrain and on parts of the prospective midbrain and hindbrain (Figure 3c) . At 14 h, expression of zPEA3 appears to be restricted to the future telencephalon in the (Xin et al., 1992) and human PEA3 (Friedman et al., 1995; Y de Launoit, unpublished data) and the related proteins human ERM (MonteÂ et al., 1994) and mouse ER81 (Brown and McKnight, 1992) . Residues which are identical in all ®ve proteins are indicated by asterisks. The highly conserved ETS-and acidic-domains are boxed and shaded forebrain ( Figure 3d ). Expression in the hindbrain appears to be restricted to anterior segments corresponding to the future rhombomeres 1 ± 4 (Figures 3d and 4a). A strong band of expression is observed anterior to the hindbrain in the position of the future midbrain/hindbrain boundary. Weak expression is also detected in the pharyngeal region at either side of the head (Figure 4a ). Gradually PEA3 expression in the fore-and hindbrain is downregulated (Figures 3e and 4d) although expression continues to be maintained strongly at the mid-/hindbrain boundary and in the neural crest cells in each pharyngeal arch (Figures 3e ± g and 4d and f). By 18 h PEA3 is also expressed in the lens primordia ( Figure 4d ). Gradually this resolves to cells around the developing lens (Figures 3h and 4f ). In addition, PEA3 is expressed in single cells along the body axis which lie either side of the notochord and are likely to represent the Rohon-Beard neurons (Figures 3f and 4g ). Expression of PEA3 in these neurons continues into the second day of development (Figure 3h ).
These data suggest a role for zebra®sh PEA3 in several developmental processes including brain development, neural crest function, neural development and somitogenesis. In all cases, PEA3 expression pre®gures the formation of distinct structures and appears to be associated with primitive, undifferentiated or poorly dierentiated cell-types.
Autoinhibition of DNA-binding by zebra®sh PEA3
The E74 DNA-binding site (containing the central 5'-CCGGAA-3' motif) represents a high anity binding site for many ETS-domain transcription factors. DNA Taken together, these results demonstrate that PEA3 DNA binding is inhibited by an intramolecular mechanism involving residues from domains located N-and C-terminal from the ETS-domain (summarized in Figure 5d ). The regions immediately¯anking the ETS-domain (II and III) appear to cooperatively inhibit DNA binding. The N-terminus of the protein (I) also plays an inhibitory role in the absence of region III, adding further complexity to the autoinhibitory process.
DNA binding speci®city of PEA3 subfamily members
Murine PEA3 was originally isolated based on its ability to bind the motif 5'-CAGGAA-3' within the polyomavirus enhancer (Xin et al., 1992) . However, the DNA binding speci®city of PEA3 subfamily members has not been investigated in detail. The binding speci®city of zebra®sh PEA3 was therefore determined using a PCR-based site-selection technique which puri®es high anity binding sites from a pool of random double-stranded oligonucleotides. The human family member ERM was also analysed. GST fusion proteins encoding the ETS-domains of zebra®sh PEA3 (GSTzPEA3-ETS) and human ERM (GSThERM-C) were incubated with a pool of double-stranded oligonucleotides containing 26 random bases (Pollock and Treisman, 1990) . Protein-DNA complexes were ]methionine using rabbit reticulocyte lysates (RRL) and equimolar amounts of each protein was analysed by SDS ± PAGE on a 12% gel. (c) The DNA-binding activity of zPEA3 and the truncated derivatives were analysed by gel retardation analysis. Equimolar amounts of each protein (indicated above each lane) were incubated with a 32 P-labelled double-stranded oligonucleotide containing the Drosophila E74 motif. Lane 9 contains a mock in vitro translation from an unprogrammed lysate (lane 9). (d) Diagrammatic summary of the three regions in PEA3 which are involved in autoinhibition of its DNA binding activity isolated by incubation with glutathione-agarose beads, unbound DNA was removed by extensive washing and remaining bound DNA was recovered and ampli®ed using PCR. This procedure was repeated a further four times. The site selection procedure was monitored after each round by gel retardation analysis using isolated radio-labelled DNA from each pool as a probe. Enrichment of binding was apparent as an increased eciency of complex formation as the number of rounds of selection increased for both zPEA3 ( Figure  6a ) and hERM (Figure 6b) .
The protein-bound DNA fragments from round three were cloned and sequenced and are shown in summary form in Figure 6c (PEA3) and d (ERM). All selected sites contained at least one GGAA/T motif and the overall consensus for each protein is virtually identical. Notable features of the consensus sites are the absolute conservation of the central GGA motif and a choice of either A or T at the +2 position. Moreover, the dinucleotide CC is strongly favoured at the 72 and 73 positions. A strong preference for a purine at position +3 and a pyrimidine at position +4 is also apparent for both proteins.
To further investigate the binding speci®city of zPEA3 and hERM, individual binding sites were tested for binding. Due to the presence of two potential ets motifs in many of the selected sites, binding sites were selected for investigation in which a single ets-motif could unambiguously be identi®ed from this and a related study on the TCF subfamily proteins Elk-1 and SAP-1 (Figure 7a ). DNA binding speci®cities of the PEA3 subfamily members were compared to those of Elk-1 and SAP-1. The results of the DNA binding assays are shown in Figure 7b ± e and summarized in Figure 7f ) zPEA3 binds each of the sites examined with a dierent eciency (Figure 7b ). In agreement with the site-selection data, the highest anity sites (S-1, S-27, S-28, S-65, E3-15 and E3-19) all contain the central CCGGAA motif. Sites with substitutions within this motif exhibit a reduction in binding eciency (e.g. S-26, P2-3, P3-22, P3-40). Furthermore, the S-31 site is bound with lower eciency despite the presence of the Sites contained single ets-motifs (central GGAA/T core is highlighted in bold) were obtained from site-selection studies using human SAP-1 (labelled`S-'; , zebra®sh PEA3 (labelled`P2/3-'; this study) or human ERM (labelled`E3-'; this study). Equimolar amounts of (b) zPEA3, (c) hERM, (d) SAP1 and (e) Elk-1 were bound to an equivalent amount of each radiolabelled probe. Protein: DNA complexes were separated from unbound DNA by electrophoresis through an 8%, 0.56 TBE, polyacrylamide gel and resulting complexes were quanti®ed by phosphorimagery. Experiments were performed two to three times for each protein. (f) Summary of the DNA binding activity of each protein to the panel of sites relative to the highest anity interaction (SAP-1 and the S-1 site)(++++, 85 ± 100%; +++, 38 ± 85%; ++, 20 ± 38%; +, 5 ± 20%; +/7, 55% central CCGGAA motif, thereby demonstrating that sequence dierences outside this motif also contribute to zPEA3 binding. The spectrum of binding anities for hERM to the same set of sites is virtually identical to that observed by zPEA3 (Figure 7c) , thereby con®rming the results of the site-selection assay which indicated that these two proteins have virtually identical DNA binding speci®cities. The spectrum of binding anities of the TCF subfamily protein Elk-1 is also very similar to that exhibited by the PEA3 subfamily members (Figure 7e) although some of the lower anity PEA3 sites (P2-3 and P3-40) are bound very weakly by Elk-1, suggesting a greater discrimination against such sites by Elk-1. In contrast, SAP-1 which exhibits a relaxed DNA-binding speci®city in comparison to Elk-1 , binds eciently to all the sites tested.
Finally, several longer zPEA3 proteins (see Figure  5a) , were tested on a panel of selected binding sites. However, the inclusion of N-and/or C-terminal domains in addition to the ETS DNA-binding domain had no eect on the binding speci®city of zPEA3 (data not shown).
Taken together, these results con®rm the data from the site-selection analysis and indicate that zebra®sh PEA3 and human ERM exhibit virtually indistinguishable DNA binding speci®cities.
Transcriptional activation by zebra®sh PEA3 is induced by the PKA and ERK MAP kinase pathways
Transcriptional activation by the mammalian members of the PEA3 subfamily is enhanced by both the ERK MAP kinase and PKA signalling pathways (Janknecht, 1996; Janknecht et al., 1996; O'Hagan et al., 1996) . The involvement of these pathways in regulating transcriptional activation by zebra®sh PEA3 was therefore tested in comparison to human ERM . Transfections were carried out in RK13 cells in the presence of a luciferase reporter gene driven by three ets-motifs. Expression of either zebra®sh PEA3 or human ERM gave little stimulation of transcription over basal levels (Figure 8a and b) . Stimulation of the ERK pathway by coexpression of BXB (constitutively active Raf-1) and ERK2 enhances reporter activity, presumably by activating endogenous ETS-domain proteins. However, when either human ERM or zebra®sh PEA3 were expressed in conjunction with the kinases, a further moderate enhancement of reporter activity was observed (Figure 8a) . In contrast to the eect seen with the ERK pathway, expression of PKA did not dramatically enhance the activity of the reporter gene. However, coexpression of either zebra®sh PEA3 or human ERM increased reporter activation by approximately ®vefold in each case (Figure 8b) .
Taken together our results are consistent with those seen previously for human ERM and indicate that zebra®sh PEA3 is also a target of the ERK MAP kinase and PKA signaling pathways.
Discussion
The function of members of the PEA3 subfamily of ETS-domain transcription factors during normal development is currently unclear. In order to further our understanding of their function, we have cloned the zebra®sh homologue of mammalian PEA3. Several lines of evidence suggest that zebra®sh PEA3 regulates transcription using a mechanism that has been remarkably conserved for this subfamily of ETSdomain proteins throughout the vertebrates. Particularly high amino acid sequence conservation is observed in the ETS-domain and N-terminal transcriptional activation domain and its DNA binding and transcriptional activation properties are very similar to its mammalian counterparts. Signi®cantly, our analysis of its expression pro®le is the ®rst evidence which suggests that it is involved in cell speci®cation in the early embryo.
DNA binding properties of zebra®sh PEA3
In common with other ETS-domain transcription factors (reviewed in Wasylyk et al., 1993; Janknecht and Nordheim, 1993) and other PEA3 subfamily members (reviewed in de Launoit et al., 1997), zebra®sh PEA3 can activate transcription from promoters containing ets-binding motifs. This transactivation potential is augmented by upstream MAP kinase cascades and the PKA pathway. It is currently unknown which MAP kinase cascade(s) target PEA3 during development or whether this targeting involves direct phosphorylation of PEA3. However the involvement of MAP kinase cascades in mutiple proliferative and developmental processes (reviewed in Treisman, 1996) makes this link an attractive route to PEA3-dependent gene activation in vivo.
DNA binding site-selection studies indicate that zebra®sh PEA3 has a virtually identical binding speci®city to human ERM. This conservation of DNA binding speci®city is consistent with the high degree of amino acid conservation between these two proteins within their ETS-domains (94% identity). The consensus site for PEA3/ERM is very similar to that selected for other ETS-domain proteins (reviewed in . However the range of sites bound eciently closely mimics those bound by Elk-1 which has a restricted speci®city in comparison to SAP-1 . This binding speci®city is consistent with the conservation of K382 and E413 with the homologous residues in the Elk-1 ETS-domain which play a major role in dictating the dierential binding speci®city of ETS-domain proteins (Shore et al., 1996) . Murine PEA3 was originally isolated by its ability to bind to the`PEA3 motif' found in the polyomavirus enhancer (Xin et al., 1992) . However, sites related to this motif are only poorly bound by PEA3 family members in comparison to other selected ets-motifs, indicating that this is in fact a suboptimal binding site.
It is probable that DNA binding alone is insucient to permit targeting of PEA3 to speci®c promoters. Interaction with other proteins such as AP-1 family members (Nakae et al., 1995) or steroid hormone receptors (Schneikert et al., 1996) can modulate the activity of PEA3 subfamily members. Other potential interaction partners may exist which contribute to binding speci®city and/or relief of DNA binding inhibition. Indeed, full-length zebra®sh PEA3 binds DNA poorly as observed previously with other family members (Xin et al., 1992; Laget et al., 1996) . Deletion analysis of zebra®sh PEA3 identi®ed both N-and Cterminal regions which are responsible for inhibiting DNA binding via the ETS-domain (Figure 5d ). Similarly, human ERM has both N-and C-terminal inhibitory domains (Laget et al., 1996) . The cooperative inhibition observed between these domains is highly reminiscent of the inhibitory mechanism used by Ets-1. In Ets-1, a-helices located N-and Cterminally to the ETS-domain are thought to interact with each other and form an inhibitory module (Jonsen et al., 1996; Skalicky et al., 1996) . Further studies are necessary to ®nd out whether a similar mechanism is employed by PEA3 subfamily members.
Expression and developmental role of zebra®sh PEA3
The expression pro®le of zebra®sh PEA3 during early development is distinct from other ETS-domain transcription factors. For example, zebra®sh¯i-1 is associated with early haematopoietic and vasculogenic processes and shows no overlap in spatial expression with PEA3 in these domains although potential overlap in expression is seen around the pharyngeal arches (Brown et al., submitted) . In contrast, the PEA3 expression pattern during early development suggests that it may control the acquisition of speci®c cell fates in the developing somites and the neural tube. PEA3 is initially expressed in the entire mesendoderm during gastrulation and remains expressed in the paraxial mesoderm. Expression of PEA3 is initially expressed in the newly formed somites and is downregulated anteriorly as somitogenesis proceeds and later marker genes such as MyoD are expressed (Weinberg et al., 1996) . This suggests that PEA3 is associated with an undierentiated state and is consistent with previous data which suggested such a role by the observation that retinoic acid-induced dierentiation of P19 cells correlates with a reduction in PEA3 expression (Xin et al., 1992) . Within the somites, PEA3 expression is restricted anteriorly and similarly, its expression appears restricted to the anterior subset of neural crest cells in each pharyngeal arch. A role for PEA3 in regulating somitogenesis is further substantiated by the observation that the mouse PEA3 homologue accelerates myogenic dierentiation and its expression is subsequently downregulated following dierentiation (Taylor et al., 1997) .
A possible link with cell movement is suggested by the expression of PEA3 in the neural crest cells which form the pharyngeal arches although an alternative role in specifying dierent neural crest cell fates cannot be discounted. In mammalian systems, PEA3 family members are thought to play a role in regulating metalloproteinase gene promoters (Higashino et al., 1995; Schneikert et al., 1996) and are overexpressed in metastatic mammary tumours (Trimble et al., 1993) which also suggests a role in regulating cell motility. Indeed, overexpression of the human PEA3 homologue is sucient to confer an invasive phenotype on human cancer cells (Kaya et al., 1996) .
Comparison of the expression pro®le of zebra®sh PEA3 with known embryonic genes, suggests potential partner proteins and/or target genes for PEA3. For example, pax-b appears to be coexpressed with PEA3 in neural cells and at the mid-hindbrain border (Krauss et al., 1991) . A direct interaction between Pax and ETS-domain proteins has previously been demonstrated on the murine MB-1 promoter (Fitzsimmons et al., 1996) . The expression of PEA3 in the somites prior to the myogenic marker gene MyoD suggests that PEA3 may represent an upstream regulator which triggers activation of this gene. The isolation of further zebra®sh genes and investigation of their expression pro®les is likely to uncover future potential targets/regulators. Future studies will be directed towards understanding the regulatory circuitry involving PEA3 that functions during early vertebrate development.
Materials and methods

Cloning of zebra®sh PEA3
A bacteriophage lgt10 cDNA library, prepared from 20 ± 24 h old zebra®sh embryos, was screened with a mix of six partial zebra®sh cDNAs encoding the central region of the ETS DNA-binding domain as described elsewhere (Brown et al., submitted) . Eight l clones were puri®ed, three of which (lZC, lZG, lZJ) contained cDNA inserts corresponding to zebra®sh PEA3. The cDNA insert was isolated as two fragments (ZC1 and ZC2) from lZC by digestion with NotI. ZC1, which encodes full-length zebra®sh PEA3, was ligated into pBluescript SK + which had been cleaved with the same enzyme to produce pAS167. pAS333 is identical to pAS167 except that the PEA3 cDNA is inserted in the opposite orientation.
Plasmid constructs
pAS462 encodes a fusion of GST and the ETS DNAbinding domain of zebra®sh PEA3 (GSTzPEA3-ETS). Amino acids 341-432 of zebra®sh PEA3 were ampli®ed by PCR from pAS333 using the primers ADS288/310. The PCR product was digested with BamHI and XbaI and ligated into pGEX-KG (Guan and Dixon, 1991) which had been digested with the same enzymes. The plasmid pGEX-ERM355-510 (encoding the C-terminus of human ERM, amino acids 355-510 (including the ETS-domain) fused to GST; GSThERM-C) was constructed by inserting the EcoRI fragment from pCRII-ERM355-510 (Janknecht et al., 1996) into the same site in pGEX.11T.
The following plasmids were prepared for producing proteins by in vitro transcription/translation. pAS280 (encoding the human SAP-1 ETS-domain; amino acids 1 ± 92) (Shore et al., 1996) and pAS72 (encoding the human Elk-1 ETS-domain; amino acids 1 ± 93) have been described previously (Shore and Sharrocks, 1994) .
pAS283 (encoding PEA3 amino acids 341 ± 432; zPEA3-ETS), pAS330 (encoding PEA3 amino acids 1 ± 432; zPEA3-N3) and pAS332 (encoding PEA3 amino acids 258 ± 432; zPEA3-ND1 ± 257) were prepared by PCR ampli®cation from pAS333 using the primers ADS288/289, ADS263/289 and ADS289/311 respectively. These PCR products were digested with NcoI and BamHI (or NcoI and XbaI in the case of pAS332) and ligated into the same sites in pAS37 (Sharrocks et al., 1993a) . pAS331 (encoding amino acids 341 ± 494; zPEA3-C) and pAS343 (encoding PEA3 amino acids 258 ± 494; zPEA3-D1-257) were prepared by PCR ampli®cation from pAS333 using the ADS288/M13 forward and ADS311/ M13 forward primers respectively, followed by cleavage with NcoI/XbaI and ligation into the same sites in pAS37. pAS342 (encoding PEA3 amino acids 1 ± 242) was prepared by PCR ampli®cation from pAS333 using the primers ADS263/316. The PCR product was digested with XbaI and XhoI and ligated into pBluescript SK + . pAS344 (encoding full-length zebra®sh PEA3 with amino acids 243 ± 257 deleted; zPEA3D243-257) was prepared by ligating an NcoI/XhoI fragment from pAS342 into pAS343 which had been digested with the same enzymes. pAS345 (encoding PEA3 amino acids 1 ± 432 with residues 243 ± 257 deleted; zPEA3-ND243-257) was prepared by ligating the NcoI/XhoI fragment from pAS332 into pAS343 which had been digested with the same enzymes. pAS477 (encoding full-length zebra®sh PEA3) was prepared by ligating the EcoRI/EcoRV fragment from pAS333 into pAS344 digested with the same enzymes. pAS496 (encoding the ETS-domain of human ERM; residues 359 ± 450) was constructed by PCR ampli®cation from pSGERMC (Laget et al., 1996) using the primers ADS348 and ADS349 followed by direct ligation into pT7Blue (Novagen) by`TA cloning'. Details of all PCR primers can be supplied on request. The nucleotide sequences of all PCR-derived constructs were veri®ed by di-deoxy sequencing.
For transient transfection assays, the E74 3 -tk80-luc reporter plasmid and overexpression vectors for the protein kinases BXB (constitutively active Raf-1), ERK2 and PKA were used as described in Janknecht (1996) and Janknecht et al. (1996) . The ERM overexpression vector pSV-ERM has been described previously (Laget et al., 1996) . The zebra®sh PEA3 overexpression vector (pAS501) was constructed by inserting the KpnI/NotI fragment from pAS477 into the same sites of pREP7.
Protein production
Puri®cation of the GST fusion proteins GSTzPEA3-ETS and GSThERM-C was carried out essentially as described previously . GST fusion proteins were eluted by incubating the beads for 10 min with 10 mM reduced glutathione, 50 mM Tris-HCl (pH 8). The eluted protein was dialysed overnight against a continuous¯ow of 16PBS (pH 7.4) and then stored at 7808C in 50% glycerol.
All in vitro translated proteins were synthesized by sequential in vitro transcription and translation from plasmids derived from the pBluescript KS + derivative pAS37 under control of the T3 promoter as described previously (Sharrocks et al., 1993a) . pAS496-derived template was transcribed using T7 RNA polymerase. Plasmid constructs were linearized by digestion with an appropriate restriction enzyme (BamHI for pAS331, pAS343, pAS344, pAS477, pAS72, XbaI for pAS331, pAS343, pAS344, pAS477 and EcoRI for pAS280 and pAS496).
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S-labelled proteins were analysed by electrophoresis through 0.1% sodium dodecylsulphate (SDS)-12% polyacrylamide gels before visualization and quanti®cation by autoradiography and phosphorimaging (BAS 1500 Phosphorimager and TINA 2.08e software, Fuji).
Gel retardation analysis
Gel retardation assays were performed as described previously (Sharrocks et al., 1993b) using 5% polyacrylamide gels cast in 0.56 Tris-borate-EDTA (TBE). DNA binding sites derived from the synthetic oligonucleotides ADS107 and ADS108 (Shore and Sharrocks, 1994) were annealed to form the high anity E74 ets binding site (upper strand 5'CTAGAGCTGAATAACCGGAAGTAA-CTCAT-3'), labelled and puri®ed as described previously (Shore et al., 1996) . Individual DNA-binding sites derived from the site-selection procedure were synthesized and labelled by PCR as described previously . Binding reactions were set up to achieve 550% binding of the free DNA to allow quanti®cation of relative DNA binding anities. To account for slight dierences in the amounts of each binding site added in each experiment, results were normalized by dividing by the total DNA present in the binding reaction.
DNA binding-site selection procedure
A random pool of radiolabelled DNA-binding sites was synthesized by annealing 1 mg of the PCR primer PF to 20 ng of oligonucleotide R76 and then synthesizing the remainder of the PF-primed second strand with DNA polymeraseI (Klenow fragment). The R76 oligonucleotide comprises 26 random pairs¯anked by regions complementary to the PCR primers PF and PmR (Pollock and Treisman, 1990; . DNA synthesis was performed using ®ve units of DNA polymeraseI (Klenow fragment) (Promega) in a reaction volume of 30 ml containing: 50 mM dGTP, 50 mM dATP, 50 mM dTTP, 2 mCi of [ 32 P]dCTP (3000 Ci/mmol) and 3 ml 106 Klenow buer [500 mM Tris-HCl (pH 7.2), 100 mM MgSO 4 , 1 mM DTT]. Reactions were carried out for 30 min at 378C and then for a further 30 min at room temperature after the addition of 1 ml of 2 mM dCTP. Radiolabelled binding sites were puri®ed by electrophoresis through 8% polyacrylamide gels. Eluted DNA was resuspended in 20 ml of water. 2 ng of this pool of radiolabelled binding sites was used for the initial DNA-binding reaction of the siteselection procedure. GSTzPEA3-ETS or GSThERM-C were bound to the random pool of synthesized binding sites as described previously . After completion of the binding reaction, 20 ml of 50% reduced glutathione agarose beads in 16PBS were added and the reaction mix incubated for 10 min at room temperature to allow binding of the GST-fusion protein to the beads. The beads were washed four times in 500 ml of wash buer [2 mM spermidine (pH 7), 2.4 mM EDTA (pH 8), 6.7 mM N-2-hydroxy-ethylpiperazine-N-2-ethanesulphonic acid (HEPES; pH 7.9), 5.3% glycerol, 0.53 mM MgCl 2 , 0.27 mM DTT, 0.027 mM ZnCl 2 , 125 mM KCl and 16 mg of bovine serum albumin]. Protein-bound DNA was eluted by resuspending the beads in 200 ml of 16TE, containing 0.1% SDS, and incubating for 10 min at 958C. Eluted DNA was ethanol precipitated in the presence of 10 mg of glycogen carrier (Boehringer Mannheim) and resuspended in 10 ml of water. 4.5 ml of the resuspended DNA pool was used as a template for ampli®cation by PCR.
Ampli®cation and cloning of the selected pools of DNA binding sites Selected pools of DNA binding sites were ampli®ed by PCR for 15 ± 20 cycles as described previously. One tenth of the ampli®ed pool of binding sites was used in the following round of selection. DNA pools from the desired rounds of selection were ampli®ed by PCR to generate sucient DNA for cloning procedures. Ampli®cation was performed, using one twentieth of each selected pool as a template, for 12 cycles under the conditions described above (except for omitting radiolabelled dCTP and increasing the concentration of unlabelled dCTP from 30 ± 50 mM). The ampli®ed DNA pools were ligated directly into pT7Blue T-vector (Novagen) via`TA cloning' and the resulting subclones sequenced by the dideoxy chain termination method.
Cell culture, transfection and extract preparation
Rabbit kidney carcinoma RK13 cells (ATCC No CCL 37) were maintained in Dulbecco medium containing 10% fetal calf serum (Gibco) and incubated at 378C in a water saturated 5% CO 2 atmosphere. Transient transfection experiments were performed using the lipofectamine procedure (Gibco-BRL) in 35 mm dishes (Monte et al., 1995; Janknecht et al., 1996) . The assays were performed as described previously (Laget et al., 1996) and the data presented are from three independent experiments using two dierent plasmid preparations.
Whole-mount in situ hybridization
Whole mount in situ hybridization experiments with antisense digoxigenin-labelled RNA probes for PEA3 were carried out as described previously (Brown et al., 1997) . Probes were synthesized using pAS167 as a template.
